Market research
WLLW.TO Willow Biosciences Inc
TO CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 2
- Dividend yield
- Not available
- Beta
- 4.65
Profile
Company facts
- Exchange
- TO
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA97111B4047
- Market cap
- 5M
- P/E ratio
- Not available
- Analyst target
- 2
- Dividend yield
- Not available
- Beta
- 4.65
About
About Willow Biosciences Inc
Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the WLLW.TO discussion.
5 years, 4 months ago
Willow Biosciences Inc is currently in a long term downtrend where the price is trading 13.1% below its 200 day moving average.
From a valuation standpoint, the stock is 1089.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12135.1.
Willow Biosciences Inc's total revenue rose by inf% to $8K since the same quarter in the previous year.
Its net income has dropped by 380.1% to $-15M since the same quarter in the previous year.
Finally, its free cash flow grew by 15.7% to $-4M since the same quarter in the previous year.
Based on the above factors, Willow Biosciences Inc gets an overall score of 2/5.